Stock listing
Frankfurt:2X10 Abivax SA Aktie
German listing (Frankfurt) of Abivax SA · home listing Euronext:ABVX
Follow Abivax SA into a list and get an email when it puts out news.
Share price · FWB:2X10
€74.00 EUR -3.50 (-4.5%)
Close on Nov 17, 2026
- Day range
- €74.00 – €74.00 EURNov 17, 2026
- Volume
- 40 sharesNov 17, 2026
- Market cap
- €6.46B EURAt the close on Nov 17, 2026 · price × 87.27M shares outstanding
- Traded on an average day
- €6,332 EURMedian day 0 shares · 46 days with no trades · last 3 months, Aug 17, 2026 – Nov 6, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| Euronext:ABVX · Home | €75.50 EUR | -1.40 (-1.8%) | 128,059 | €75.20 | €76.15 | €74.25 | €76.90 | Close on Nov 17, 2026 |
| NASDAQ:ABVX | $82.10 USD | -1.51 (-1.8%) | 1,372,710 | $82.86 | $84.31 | $81.83 | $83.61 | Close on Nov 17, 2026 |
| LSE:0RA9 | €75.15 EUR | -1.75 (-2.3%) | 2,062 | €76.00 | €76.00 | €74.60 | €76.90 | Close on Nov 17, 2026 |
| OTC:AAVXF | $84.80 USD | 0.00 (0.0%) | — | $84.80 | $84.80 | $84.80 | $84.80 | Close on Nov 6, 2026 |
| Frankfurt:2X1 | €77.00 EUR | +1.15 (+1.5%) | 101 | €74.65 | €77.00 | €74.65 | €75.85 | Close on Nov 17, 2026 |
| Frankfurt:2X10 | €74.00 EUR | -3.50 (-4.5%) | 40 | €74.00 | €74.00 | €74.00 | €77.50 | Close on Nov 17, 2026 |
Daily closes
Last 3 months, Aug 17, 2026 – Nov 6, 2026 · FWB:2X10 · EUR, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| €75.03 | -0.561 | -0.7% | €74.20 | €75.92 | €73.35 | 0 | |
| €75.59 | -2.565 | -3.3% | €78.52 | €78.88 | €75.37 | 0 | |
| €78.16 | +0.244 | +0.3% | €77.75 | €78.23 | €77.73 | 1,190 | |
| €77.91 | +3.178 | +4.3% | €73.01 | €78.87 | €72.70 | 800 | |
| €74.73 | -3.62 | -4.6% | €76.89 | €76.97 | €74.51 | 0 | |
| €78.35 | +0.028 | 0.0% | €78.35 | €78.35 | €78.35 | 2 | |
| €78.33 | +1.241 | +1.6% | €78.33 | €78.33 | €78.33 | 1,200 | |
| €77.09 | -0.816 | -1.0% | €77.09 | €77.09 | €77.09 | 200 | |
| €77.90 | +0.384 | +0.5% | €75.79 | €78.40 | €75.37 | 0 | |
| €77.52 | -1.565 | -2.0% | €78.03 | €78.38 | €77.14 | 14 | |
| €79.08 | -2.284 | -2.8% | €79.08 | €79.08 | €79.08 | 0 | |
| €81.37 | -1.327 | -1.6% | €81.37 | €81.37 | €81.37 | 0 | |
| €82.69 | +0.826 | +1.0% | €81.59 | €83.01 | €80.87 | 0 | |
| €81.87 | +3.763 | +4.8% | €78.71 | €82.04 | €78.61 | 0 | |
| €78.10 | -3.213 | -4.0% | €78.10 | €78.10 | €78.10 | 0 | |
| €81.32 | +0.625 | +0.8% | €80.57 | €81.68 | €80.34 | 0 | |
| €80.69 | +5.71 | +7.6% | €76.37 | €81.01 | €75.39 | 0 | |
| €74.98 | -1.661 | -2.2% | €74.98 | €74.98 | €74.98 | 0 | |
| €76.64 | -1.561 | -2.0% | €76.93 | €77.04 | €76.64 | 0 | |
| €78.20 | +0.975 | +1.3% | €78.20 | €78.20 | €78.20 | 0 | |
| €77.23 | +0.698 | +0.9% | €77.23 | €77.23 | €77.23 | 124 | |
| €76.53 | +0.454 | +0.6% | €76.53 | €76.53 | €76.53 | 102 | |
| €76.08 | -2.67 | -3.4% | €76.56 | €76.95 | €75.79 | 0 | |
| €78.75 | -3.253 | -4.0% | €78.78 | €78.78 | €78.03 | 0 | |
| €82.00 | -0.034 | 0.0% | €82.00 | €82.00 | €82.00 | 0 | |
| €82.03 | -3.294 | -3.9% | €82.03 | €82.03 | €82.03 | 300 | |
| €85.33 | +0.59 | +0.7% | €85.49 | €85.53 | €85.28 | 0 | |
| €84.74 | +0.963 | +1.1% | €84.74 | €84.74 | €84.74 | 0 | |
| €83.78 | +4.553 | +5.7% | €83.78 | €83.78 | €83.78 | 0 | |
| €79.22 | -0.623 | -0.8% | €79.22 | €79.22 | €79.22 | 0 | |
| €79.85 | -1.85 | -2.3% | €79.85 | €79.85 | €79.85 | 0 | |
| €81.70 | +0.238 | +0.3% | €81.41 | €82.31 | €80.98 | 0 | |
| €81.46 | -4.128 | -4.8% | €85.64 | €85.92 | €81.40 | 0 | |
| €85.59 | -3.558 | -4.0% | €89.23 | €89.23 | €84.92 | 0 | |
| €89.14 | -1.825 | -2.0% | €90.98 | €91.70 | €88.84 | 0 | |
| €90.97 | +1.421 | +1.6% | €91.29 | €91.29 | €90.38 | 8 | |
| €89.55 | -2.584 | -2.8% | €89.55 | €89.55 | €89.55 | 0 | |
| €92.13 | +0.086 | +0.1% | €92.13 | €92.13 | €92.13 | 100 | |
| €92.05 | -6.679 | -6.8% | €95.60 | €96.22 | €92.03 | 0 | |
| €98.72 | -0.765 | -0.8% | €100.48 | €101.08 | €97.85 | 0 | |
| €99.49 | -4.302 | -4.1% | €99.49 | €99.49 | €99.49 | 0 | |
| €103.79 | +2.354 | +2.3% | €103.79 | €103.79 | €103.79 | 0 | |
| €101.44 | +1.126 | +1.1% | €100.37 | €102.76 | €100.31 | 0 | |
| €100.31 | +3.919 | +4.1% | €96.83 | €100.99 | €96.15 | 0 | |
| €96.39 | +0.283 | +0.3% | €96.39 | €96.39 | €96.39 | 0 | |
| €96.11 | +1.644 | +1.7% | €96.11 | €96.11 | €96.11 | 216 | |
| €94.47 | -1.124 | -1.2% | €94.47 | €94.47 | €94.47 | 0 | |
| €95.59 | +1.445 | +1.5% | €95.59 | €95.59 | €95.59 | 0 | |
| €94.14 | -2.266 | -2.4% | €94.14 | €94.14 | €94.14 | 0 | |
| €96.41 | -0.544 | -0.6% | €96.41 | €96.41 | €96.41 | 0 | |
| €96.95 | -1.636 | -1.7% | €96.95 | €96.95 | €96.95 | 216 | |
| €98.59 | -1.186 | -1.2% | €98.59 | €98.59 | €98.59 | 0 | |
| €99.78 | +0.972 | +1.0% | €99.78 | €99.78 | €99.78 | 0 | |
| €98.80 | +0.973 | +1.0% | €98.80 | €98.80 | €98.80 | 0 | |
| €97.83 | -1.772 | -1.8% | €97.83 | €97.83 | €97.83 | 0 | |
| €99.60 | -1.952 | -1.9% | €99.60 | €99.60 | €99.60 | 204 | |
| €101.56 | -0.181 | -0.2% | €101.56 | €101.56 | €101.56 | 0 | |
| €101.74 | +1.454 | +1.4% | €101.74 | €101.74 | €101.74 | 0 | |
| €100.28 | -1.812 | -1.8% | €100.28 | €100.28 | €100.28 | 0 | |
| €102.09 | -3.091 | -2.9% | €101.61 | €103.86 | €101.32 | 0 |
- Ticker
- Frankfurt:2X10
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Frankfurt
- Currency
- EUR
What changed lately
Latest news release · Nov 2, 2026
Abivax to Participate in Upcoming Fall Investor Conferences
Latest deck · July 2026
Investor Presentation (July 2026)
Investor deck · 87 slides
Calls
Replays
Abivax (Euronext:ABVX) Q4 2023 Earnings Call
Mon, Apr 08, 2024 · 8:30 AM ET
Watch Transcript
Latest news
Abivax to Participate in Upcoming Fall Investor Conferences
Nov 2, 2026
Closed €77.91 (+4.3%) on Nov 3, 2026
Abivax participera à plusieurs conférences investisseurs cet automne
Nov 2, 2026
Closed €74.73 (-4.6%) on Nov 2, 2026
ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 30.09.26
Oct 23, 2026
Closed €79.08 (-2.8%) on Oct 23, 2026
Abivax to Present Data on Obefazimod at United European Gastroenterology (UEG) Week 2026
Sep 30, 2026
Closed €85.33 (+0.7%) on Oct 1, 2026
Abivax présentera des données sur l’obéfazimod lors de l’United European Gastroenterology (UEG) Week 2026
Sep 30, 2026
Closed €84.74 (+1.1%) on Sep 30, 2026
ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 31.08.26
Sep 25, 2026
Closed €79.85 (-2.3%) on Sep 25, 2026
Abivax Presents Business Updates and First Half 2026 Financial Results
Sep 21, 2026
Closed €85.59 (-4.0%) on Sep 22, 2026
Abivax Announces Positive Pre-NDA Interaction with the FDA for Obefazimod
Jul 30, 2026
Closed €107.61 (+3.8%) on Jul 31, 2026
Abivax Strengthens Commercial Capabilities With Strategic Leadership Appointments
Jul 23, 2026
Closed €112.91 (+0.7%) on Jul 24, 2026
Abivax Announces Closing of $920 Million Public Offering
Jul 6, 2026
Closed €124.71 (-6.1%) on Jul 7, 2026
Financings
Public offering of american Depositary Shares
Jul 6, 2026
Closed: US$920M raised · Leerink Partners +5
Dealers: Leerink Partners (co-lead), Morgan Stanley (co-lead), Piper Sandler (co-lead), Guggenheim Securities (co-lead), LifeSci Capital, Van Lanschot Kempen
Use of proceeds: Together with existing cash, to finance operations into the fourth quarter of 2029
Public offering of american Depositary Shares
Jul 2, 2026
Made bigger: about US$920M · US$125 a share · Leerink Partners +5
Dealers: Leerink Partners (co-lead), Morgan Stanley & Co. LLC (co-lead), Piper Sandler & Co. (co-lead), Guggenheim Securities, LLC (co-lead), LifeSci Capital, Van Lanschot Kempen
Use of proceeds: Potential US commercialization of obefazimod, clinical R&D mainly in ulcerative colitis and Crohn's disease, and general corporate purposes
Announced Jun 30, 2026 · Made bigger Jul 1, 2026 · Made bigger Jul 2, 2026
Public offering of american Depositary Shares
Jul 28, 2025
Closed: US$747.5M raised · US$64 a share · Leerink Partners +5
Dealers: Leerink Partners (co-lead), Piper Sandler & Co. (co-lead), Guggenheim Securities, LLC (co-lead), LifeSci Capital, BTIG, Van Lanschot Kempen
Use of proceeds: Finance operations into the fourth quarter of 2027, giving 12 months of cash runway after the planned NDA submission for Ulcerative Colitis
Announced Jul 23, 2025 · Update Jul 24, 2025 · Made bigger Jul 25, 2025 · Closed Jul 28, 2025
Decks
Investor Presentation (July 2026)
Investor deck · 87 slides · July 2026
Corporate Update (June 2026)
Corporate update · 56 slides · Jun 29, 2026
Investor Presentation (June 2023)
Investor deck · 35 slides · June 2023
Investor Presentation (May 2023)
Investor deck · 35 slides · May 2023
Abivax SA on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 30 in the last 12 months · 49 in all · newest Nov 2, 2026 · oldest 2025
- Calls
- 1 call with a replay · 1 with a transcript · latest Apr 8, 2024
- Decks
- 39 decks · latest July 2026
Where Abivax SA is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| Euronext:ABVX · Home listing | Euronext | France | EUR |
| NASDAQ:ABVX | NASDAQ | United States | USD |
| LS Exchange:A14UQC | LS Exchange | Germany | EUR |
| gettex:2X1 | gettex | Germany | EUR |
| LSE:0RA9 | LSE | United Kingdom | EUR |
| Xetra:2X1 | Xetra | Germany | EUR |
| Tradegate:2X1 | Tradegate | Germany | EUR |
| OTC:AAVXF | OTC | United States | USD |
| Lang & Schwarz:A14UQC | Lang & Schwarz | Germany | EUR |
| Aquis:ABVXP | Aquis | United Kingdom | EUR |
| Frankfurt:2X1 | Frankfurt | Germany | EUR |
| gettex:2X10 | gettex | Germany | EUR |
| BX Swiss:ABVX | BX Swiss | Switzerland | CHF |
| Dusseldorf:2X1 | Dusseldorf | Germany | EUR |
| Lang & Schwarz:A3EWCP | Lang & Schwarz | Germany | EUR |
| Munich:2X1 | Munich | Germany | EUR |
| Hamburg:2X1 | Hamburg | Germany | EUR |
| Aquis:ABVXP | Aquis | United Kingdom | EUR |
| BOATS:ABVX | BOATS | United States | USD |
| Frankfurt:2X10 · This page | Frankfurt | Germany | EUR |
| LS Exchange:A3EWCP | LS Exchange | Germany | EUR |
| Stuttgart:2X1 | Stuttgart | Germany | EUR |
| Turquoise:ABVXP | Turquoise | United Kingdom | EUR |
| VIE:ABVX | Vienna | Austria | EUR |
| Dusseldorf:2X10 | Dusseldorf | Germany | EUR |
| Hamburg:2X10 | Hamburg | Germany | EUR |
| Munich:2X10 | Munich | Germany | EUR |
| Stuttgart:2X10 | Stuttgart | Germany | EUR |
| Tradegate:2X10 | Tradegate | Germany | EUR |
| Hanover:2X1 | Hanover | Germany | EUR |
Log in to ask 6ix AI your own questions about Abivax SA.